EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions

E C Toffoli iD, A A van Vliet, C Forbes, A J Arns, H W M Verheul, J Tuynman, H J van der Vliet, J Spanholtz, T D de Gruijl

Clinical and Experimental Immunology · 2024

DOI: 10.1093/cei/uxae007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2024. Verfasst von E C Toffoli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Amsterdam UMC location Vrije Universiteit, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Killer Cells, Natural, Dendritic Cells, Monocytes, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Glycostem Therapeutics BV.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells are innate lymphocytes capable to recognize and kill virus-infected and cancer cells. In the past years, the use of allogeneic NK cells as anti-cancer therapy gained interest due to their ability to induce graft-versus-cancer responses without causing graft-versus-host disease and multiple protocols have been developed to produce high numbers of activated NK cells. While the ability of these cells to mediate tumor kill has been extensively studied, less is known about their capacity to influence the activity of other immune cells that may contribute to a concerted anti-tumor response in the tumor microenvironment (TME). In this study, we analyzed how an allogeneic off-the-shelf cord blood stem cell-derived NK-cell product influenced the activation of dendritic cells (DC). Crosstalk between NK cells and healthy donor monocyte-derived DC (MoDC) resulted in the release of IFNγ and TNF, MoDC activation, and the release of the T-cell-recruiting chemokines CXCL9 and CXCL10. Moreover, in the presence of prostaglandin-E2, NK cell/MoDC crosstalk antagonized the detrimental effect of IL-10 on MoDC maturation leading to higher expression of multiple (co-)stimulatory markers. The NK cells also induced activation of conventional DC2 (cDC2) and CD8+ T cells, and the release of TNF, GM-CSF, and CXCL9/10 in peripheral blood mononuclear cells of patients with metastatic colorectal cancer. The activated phenotype of MoDC/cDC2 and the increased release of pro-inflammatory cytokines and T-cell-recruiting chemokines resulting from NK cell/DC crosstalk should contribute to a more inflamed TME and may thus enhance the efficacy of T-cell-based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalDendritic CellsMonocytesInflammationNeoplasmsHumansLymphocyte ActivationTumor MicroenvironmentDinoprostoneChemokine CXCL9Chemokine CXCL10Allogeneic CellsCytokinesInterferon-gammaCells, Cultured

Stichwörter der Autor:innen

dendritic cellsmonocytesnatural killer cells

Substanzen

DinoprostoneChemokine CXCL9Chemokine CXCL10CytokinesInterferon-gamma

Autor:innen und Institutionen

  • Department of Medical Oncology, Amsterdam UMC location Vrije Universiteit, Amsterdam, The Netherlands.
  • Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.
  • Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands.
  • Glycostem Therapeutics, Oss, The Netherlands.
  • Department of Molecular Cell Biology and Immunology, Amsterdam UMC location Vrije Universiteit, Amsterdam, The Netherlands.
  • Department of Medical Oncology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

ORCID-Profile: E C Toffoli

Förderung

  • Glycostem Therapeutics BV

Zitieren

APA

Toffoli, E. C., van Vliet, A. A., Forbes, C., Arns, A. J., Verheul, H. W. M., Tuynman, J., van der Vliet, H. J., Spanholtz, J., & de Gruijl, T. D. (2024). Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxae007

Vancouver

Toffoli EC, van Vliet AA, Forbes C, Arns AJ, Verheul HWM, Tuynman J, et al. Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions. Clinical and Experimental Immunology. 2024. doi:10.1093/cei/uxae007

BibTeX
@article{Toffoli2024,
  author = {Toffoli, E C and van Vliet, A A and Forbes, C and Arns, A J and Verheul, H W M and Tuynman, J and van der Vliet, H J and Spanholtz, J and de Gruijl, T D},
  title = {Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions},
  journal = {Clinical and Experimental Immunology},
  year = {2024},
  doi = {10.1093/cei/uxae007}
}
Kostenlos starten →